In Section C, members will get ABBV-744 and oral navitoclax. In Section D, members will obtain ABBV-744 and ruxolitinib. Individuals will obtain treatment right until illness progression or even the contributors are unable to tolerate the study drugs. - Participant eaten grapefruit or grapefruit merchandise within three times prior to https://abbv-744-combination-ther45790.yomoblog.com/38352755/what-does-new-advancements-in-brd4-inhibition-therapy-abbv-744-mean